456 filings
Page 3 of 23
8-K
o4x7y5 5zs5cxk8ars
6 Dec 21
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3
5:16pm
8-K
pls85qg01oalsy
8 Nov 21
Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results
4:15pm
8-K
so65ac xx
5 Nov 21
Acadia Pharmaceuticals Appoints Brendan Teehan, Executive Vice President, Chief Operating Officer, Head of Commercial
4:31pm
8-K
mloqrfmi4czdnbz
2 Sep 21
Departure of Directors or Certain Officers
5:00pm
8-K
k8s k5s8qfn3smeb7
4 Aug 21
Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:15pm
8-K
56yjyjy256c
24 Jun 21
Submission of Matters to a Vote of Security Holders
5:01pm
DEFR14A
6h04 tw8z
12 May 21
Revised proxy
4:21pm
8-K
epjjcmwl
5 May 21
Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results
4:19pm
8-K
l4qnw0h
5 Apr 21
Regulation FD Disclosure
8:08am
SEC STAFF
e7ol89syw40obl1
2 Apr 21
SEC staff action: Order
12:00am
8-K
0fzc krs2
8 Mar 21
Acadia Pharmaceuticals Provides Regulatory Update on Supplemental New Drug Application for Pimavanserin for the Treatment of
4:30pm
SEC STAFF
66a65udcoxe
5 Mar 21
SEC staff action: Order
12:00am
8-K
rlqvau
24 Feb 21
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
4:10pm
8-K
acrmlmdrg4u v2
27 Jan 21
Departure of Directors or Certain Officers
5:26pm
8-K
sr5ldgu
4 Nov 20
Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:37pm